Amlodipine camsylate is a dihydropyridine calcium channel blocker used primarily in the clinical management of hypertension and angina pectoris. By inhibiting calcium ion influx across vascular smooth… Read more
Amlodipine camsylate is a dihydropyridine calcium channel blocker used primarily in the clinical management of hypertension and angina pectoris. By inhibiting calcium ion influx across vascular smooth muscle and cardiac muscle membranes, this therapeutic agent effectively promotes vasodilation to reduce blood pressure. As a distinct salt form of the amlodipine molecule, it requires rigorous monitoring during pharmaceutical development to ensure safety and therapeutic efficacy. This category provides essential reference standards for amlodipine camsylate, alongside a comprehensive selection of related impurities, metabolites, and stable isotope labelled compounds. These high-quality materials are critical for laboratories conducting impurity profiling, method validation, and routine quality control. Utilizing these characterized standards allows researchers to accurately identify degradants and quantify drug content, ensuring adherence to regulatory guidelines throughout the manufacturing and stability testing of this cardiovascular medication.